Genentech terminates agreement for Nykode cancer vaccine program | Markets Insider

Retrieved on: 2024-11-08 19:24:21

Tags for this article:

Click the tags to see associated articles and topics

Genentech terminates agreement for Nykode cancer vaccine program | Markets Insider. View article details on hiswai:

Excerpt

Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its decisio.

Article found on: markets.businessinsider.com